International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson’s Disease – Nasdaq
|
International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson's Disease
Nasdaq 07, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today reported that two more patients with … |
